Carotid Disease & Stroke
Conference Coverage
CVD-REAL 2: Lower mortality, CV risks with SGLT-2i vs. DPP-4i treatment in T2DM
ORLANDO – SGLT2 inhibitor treatment, compared with DPP-4 inhibitors, is associated with lower death, CV event, and stroke rates in patients with...
From the Journals
Stroke-smoking link is dose dependent in young men
Smoking cessation is the goal, but every little bit helps.
From the Journals
Stroke patients benefited from CPAP
Significantly more OSA patients with a recent history of stroke experienced an improvement in their Modified Rankin Scale score after using CPAP,...
Conference Coverage
Impaired kidney function no problem for dabigatran reversal
ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.
Conference Coverage
Clopidogrel flunks platelet reactivity control test in TAVI
WASHINGTON – For platelet reactivity after TAVI, ticagrelor is more effective than clopidogrel.
Conference Coverage
Apixaban prevails in study of 163,000 DOAC users
ORLANDO – Apixaban had lowest rates of both stroke and major bleeding in ARISTOPHANES.
Conference Coverage
Common infections are potent risk factor for MI, stroke
ORLANDO – Huge U.K. registry identifies a novel cardiovascular risk factor: hospitalization for UTI or respiratory infection.
News
Post-ACS death lowered in ODYSSEY Outcomes
ORLANDO – Mortality and major adverse cardiovascular events were cut 15%, but that’s not all.
Conference Coverage
Adding hypertension in pregnancy doesn’t refine ASCVD risk prediction tool
ANAHEIM, CALIF. – The 2013 ASCVD Risk Calculator doesn’t do a better job of predicting 10-year risk in women when a history of hypertensive...
From the Journals
How to lower occupational radiation exposure in the cath lab
Creative shielding can lower the risk significantly.